FORM SC 13D

Company

Mereo BioPharma Group plc

Filed

December 17, 2018

Accession Number

0000950103-18-014700

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →